>Our Speakers<
Glycotope
Technical University of Denmark
GSK
Bilfinger Industrietechnik Salzburg
Glycotope
Bilfinger
Industrietechnik Salzburg
Technical University of Denmark
MERCK
GSK
MERCK
GSK
Bilfinger
Industrietechnik Salzburg
Berlin Institute of Technology
Vienna University of Technology
Bayer
CPI Bioloigics
Berlin Institute of Technology
Novasign
Vienna University of Technology
Berlin Institute of Technology
Novasign
Vienna University of Technology
CPI Bioloigics
Takeda
Bayer
Takeda
Bayer
CPI Bioloigics
>Forum Introduction<
Today’s Bioprocessing is the base of several emerging industries and technologies, including the production of therapeutic stem cells, gene therapy vectors, and new vaccines. Advances in Bioprocessing is a particular interest to the industry as it considerably shortens the development timeline, improves the final product and increase the productivity of Bio-manufacturing facilities.
Cparity’s World Smart Bioprocessing: Pharma 4.0 Summit is launching a world platform across the Pharma & Biopharmaceutical Manufacturing community to present their technological advances, to boost innovation and exchange insights on current challenges. The event will gather top leaders in a 3-day event, aiming to promote a high level participation to provide the appropriate environment for dialogue with peers from pharma, biotech, schools, and pharma suppliers to maximize our efforts and profit in the industry.
This Summit program comprises complex case studies, workshops, panels and breakouts. It will combine forward-thinking leaders from different industries to discuss a range of topics on Bioprocessing and Smart manufacturing. We will approach main challenges, innovations and new technologies.
Join our event to learn and get inspired from world leading industry experts and improve your business performance!
Key Topics
PRODUCT LIFE
CYCLE
– Transforming upstream bioprocessing: the bioreactor digital twin as an archetype of pharma 4.0
– Genetic stability
– Strategies for developing vaccines from early phase development to a commercial product
– Stakeholder perspectives on the cross-functional process of a new product launch
– Scale-up technologies: development and manufacturing processes and validation
– Evolution of product quality attributes during the upstream and downstream process
TECHNOLOGIZING ATMP/CELL
AND GENE THERAPY
– Lentiviral vector manufacturing and analytics – opportunities, challenges and ways forward
– The use of high-throughout technologies to facilitate cell line characterization and development
– Evaluation of novel harvest methods for the clarificiation of cell culture material
– Delivering a globally compliant allogeneic cell therapy for low back pain
– Optimising cell line development: applications for furthering biopharma r&d strateg
CONTINUOUS
BIOMANUFACTURING
– Digitalization platform and supervisory control for continuous integrated manufacture of monoclonal antibodies
– Development of continuous purification strategies for therapeutic bioparticles
– Integrated process modelling: a companion from process development to control strategy
– Digitalization and big data in biopharma – vice or virtue?
– Model-based control and integrated bio manufacturing processes
PHARMA 4.0/SMART
MANUFACTURING
– Biopharmaceutical process models in the digital age – how to make value out of data
– Analytical characterisation of novel high potency neurotoxin therapeutics
– Digitalisation of raw material data and application of data analytics to increase understanding and control variation automated material
– Traceability in end-to-end continuous biomanufacturing for batch disposition
– The new age of smart continuous manufacturing as market moves to commercial
PRODUCT LIFE
CYCLE
– Transforming upstream bioprocessing: the bioreactor digital twin as an archetype of pharma 4.0
– Genetic stability
– Strategies for developing vaccines from early phase development to a commercial product
– Stakeholder perspectives on the cross-functional process of a new product launch
– Scale-up technologies: development and manufacturing processes and validation
– Evolution of product quality attributes during the upstream and downstream process
CONTINUOUS
BIOMANUFACTURING
– Digitalization platform and supervisory control for continuous integrated manufacture of monoclonal antibodies
– Development of continuous purification strategies for therapeutic bioparticles
– Integrated process modelling: a companion from process development to control strategy
– Digitalization and big data in biopharma – vice or virtue?
– Model-based control and integrated bio manufacturing processes
PHARMA 4.0/SMART
MANUFACTURING
– Biopharmaceutical process models in the digital age – how to make value out of data
– Analytical characterisation of novel high potency neurotoxin therapeutics
– Digitalisation of raw material data and application of data analytics to increase understanding and control variation automated material
– Traceability in end-to-end continuous biomanufacturing for batch disposition
– The new age of smart continuous manufacturing as market moves to commercial
TECHNOLOGIZING ATMP/CELL
AND GENE THERAPY
– Lentiviral vector manufacturing and analytics – opportunities, challenges and ways forward
– The use of high-throughout technologies to facilitate cell line characterization and development
– Evaluation of novel harvest methods for the clarificiation of cell culture material
– Delivering a globally compliant allogeneic cell therapy for low back pain
– Optimising cell line development: applications for furthering biopharma r&d strateg
Who Should Attend
– Those working in technologies to scale up bioprocesses for biologics, vaccines, related species for clinical trials or scale-up to commercialization
– Pharma 4.0
– Engineering
– Principal scientist
– Research scientist
– Technical operations
– Technical development
– Biologics development
– Drug substance
– Quality
– Process development
– R&d engineer
– Cell line development
– Downstream processing
– Technical operations
– Technical development
– Biologics development
– Drug substance
– Quality
– Process development
– R&d engineer
– Cell line development
– Downstream processing
– Those working in technologies to scale up bioprocesses for biologics, vaccines, related species for clinical trials or scale-up to commercialization
– Pharma 4.0
– Engineering
– Principal scientist
– Research scientist
– Technical operations
– Technical development
– Biologics development
– Drug substance
– Quality
– Process development
– R&d engineer
– Cell line development
– Downstream processing
– Technical operations
– Technical development
– Biologics development
– Drug substance
– Quality
– Process development
– R&d engineer
– Cell line development
– Downstream processing
Sponsors
Media Partners
The Venue
European Business Center,
Dukelských Hrdinů 564/34,
Prague 7 170 00,
Czech Republic
[email protected]
+420 210 022 094
19-21 Crawford Street,
W1H 1PJ,
London, England
[email protected]
+442031291774
IPRASENSE is headquartered in Montpellier (France). The company is focused on the development and commercialization of innovative cell culture monitoring equipments from early biological research to biopharmaceutical industry and therapeutic molecule production.
IPRASENSE reinvents the automated cell counter and viability analyzers. Our unique label-free imaging technology provides extremely fast cell count and viability from a few μl sample volume of your cell suspension. The unmatched repeatability directly results from the extremely large field of view of the single analyzed image, together with the sample preparation free method (no dilution, no label like trypan blue).
Our strategy is based on early Research and Development efforts along with market knowledge to continuously launch breaking solutions products and services to our customers.
VISIT THE WEB SITE: https://www.iprasense.com/
ChemoMetec is a worldwide leading manufacturer in the areas of cell counting and analysis. We are growing exponentially, striving towards our goal to be the number one provider of cell counters and analyzers in every segment of the biotech industry.
VISIT THE WEB SITE: https://chemometec.com/
Joining a BioPartner UK Delegation means your company attends as part of the UK Pavilion, a highly visible and recognisable brand that draws in business in the competitive global market. BioPartner UK Delegation companies receive benefits over and above those available at the event.
VISIT THE WEB SITE: http://biopartner.co.uk/
PharmaVOICE is a resource for life-sciences executives and other healthcare-service related professionals. PharmaVOICE is published by PharmaLinx LLC.
The primary audience is made up of executive and corporate management from pharmaceutical, biotechnology, drug delivery, marketing communications, clinical services, contract research, drug development, and information technology companies, as well as other industry sectors. Additionally, PharmaVOICE has readers from around the world.
PharmaVOICE.com provides access to all of the articles that have appeared in the print publication PharmaVOICE. PharmaVOICE.com also provides an online calendar of industry events, and other online content, supported by a robust search engine.
VISIT THE SITE: https://www.pharmavoice.com/
Towards a different society through sustainability and innovation. The Biobased Society Blog reports on the development towards green chemistry.
He will challenge entrenched wisdom and highlight new developments. He will provide not only facts, but also analysis and commentary.
He will not only highlight the new value chains (from agriculture to green plastics to medical applications and organic solar cells), but also the cultural,
social and political developments that arise from them (or that slow them down).
VISITE THE SITE:
https://www.biobasedpress.eu/
Gene Therapy Net is the web resource for patients and professionals interested in gene therapy. The objectives of Gene Therapy Net are to be the information resource for basic and clinical research in gene therapy, cell therapy, and genetic vaccines, and to serve as a network in the exchange of information and news related to above areas. In addition, Gene Therapy Net provides an overview for sponsors and researchers of the different international regulations and guidelines associated with clinical gene therapy trials.
VISIT THE SITE: http://www.genetherapynet.com/
For more than 30 years, Miltenyi Biotec has played an important role in the design, development, manufacture, and integration of products that empower the advancement of biomedical research and enable cell and gene therapy.
VISIT THE WEB SITE:
Genedata Selector provides the foundation for rational design of production cell lines, by delivering comprehensive gene annotation, predicting optimal CRISPR gene editing sites, and calculating all variations in genes of interest within proprietary host cell lines based on RNAseq data. The software platform also supports the automation of clone selection workflows, for example by including efficient data analysis workflows to check integration sites and detect mutations for the analysis of TLA-based experiments. On a more general level, Genedata Selector has been specifically designed to process and interpret huge amounts of complex NGS data in the context of rational cell line development with additional applications such as adventitious agent detection.
VISIT OUR WEB SITE: https://www.genedata.com/
Körber is a leading international technology group that has around 10,000 employees all over the world. We are the home for entrepreneurs —we turn entrepreneurial thinking into customers success. Körber AG manages the Group and its five Business Areas: Digital, Pharma, Supply Chain , Tissue, and Tobacco.
VISIT THE WEB SITE:
Environmental, Health & Safety considerations are an integrated part of our every day work. Our main concerns include reducing atmospheric emissions of organic solvents from the production process, and carbon dioxide from the production of energy, also preventing any contact with chemicals.
VISIT THE SITE: https://novonordiskpharmatech.com/